IL-21-expressing cells exhibited greater cytotoxicity to tumor cells and greater survival in mice than IL-15 or IL-2 treated CAR-T cells despite higher levels of IFN-γ and Bcl-2 expression (43, 50, 51). The gene discussed is IL21; the disease is neoplasm.